RudaCure Inc., a venture company specializing in the development of treatments for troubles sensoriels, a annoncé le 30th that its self-developed traitement de la sécheresse oculaire substance candidate RCI001 a été reconnue pour its commercialization potential and a été sélectionnée pour le Ministère de Trade, Industry and Energy's 'R&D Rediscovery Project,' the Ministère de SMEs and Startups' '2020 BIG3 Sector SME Innovation Growth Support Project,' and Incheon Technopark's 'Startup Park Project,' thereby laying the foundation for essais cliniques.
https://www.donga.com/news/It/article/all/20200729/102213491/2